761 related articles for article (PubMed ID: 28034684)
1. Thirty-day Outcome Following CoreValve Evolut R Transcatheter Aortic Valve Implantation: An All-comers Prospective Study.
Perrin N; Roffi M; Frei A; Hachulla AL; Ellenberger C; Müller H; Cikirikcioglu M; Licker M; Noble S
Rev Esp Cardiol (Engl Ed); 2017 Sep; 70(9):713-719. PubMed ID: 28034684
[TBL] [Abstract][Full Text] [Related]
2. Comparative Matched Outcome of Evolut-R vs CoreValve Transcatheter Aortic Valve Implantation.
Landes U; Bental T; Barsheshet A; Assali A; Vaknin Assa H; Levi A; Orvin K; Kornowski R
J Invasive Cardiol; 2017 Feb; 29(2):69-74. PubMed ID: 28145874
[TBL] [Abstract][Full Text] [Related]
3. Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: A case-matched comparison.
Giannini C; De Carlo M; Tamburino C; Ettori F; Latib AM; Bedogni F; Bruschi G; Presbitero P; Poli A; Fabbiocchi F; Violini R; Trani C; Giudice P; Barbanti M; Adamo M; Colombo P; Benincasa S; Agnifili M; Petronio AS
Int J Cardiol; 2017 Sep; 243():126-131. PubMed ID: 28595747
[TBL] [Abstract][Full Text] [Related]
4. 1-Year Outcomes With the Evolut R Self-Expanding Transcatheter Aortic Valve: From the International FORWARD Study.
Manoharan G; Van Mieghem NM; Windecker S; Bosmans J; Bleiziffer S; Modine T; Linke A; Scholtz W; Chevalier B; Gooley R; Zeng C; Oh JK; Grube E
JACC Cardiovasc Interv; 2018 Nov; 11(22):2326-2334. PubMed ID: 30466832
[TBL] [Abstract][Full Text] [Related]
5. Initial Experience of a Second-Generation Self-Expanding Transcatheter Aortic Valve: The UK & Ireland Evolut R Implanters' Registry.
Kalra SS; Firoozi S; Yeh J; Blackman DJ; Rashid S; Davies S; Moat N; Dalby M; Kabir T; Khogali SS; Anderson RA; Groves PH; Mylotte D; Hildick-Smith D; Rampat R; Kovac J; Gunarathne A; Laborde JC; Brecker SJ
JACC Cardiovasc Interv; 2017 Feb; 10(3):276-282. PubMed ID: 28183467
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Symptomatic Severe Aortic Stenosis With a Novel Resheathable Supra-Annular Self-Expanding Transcatheter Aortic Valve System.
Manoharan G; Walton AS; Brecker SJ; Pasupati S; Blackman DJ; Qiao H; Meredith IT
JACC Cardiovasc Interv; 2015 Aug; 8(10):1359-1367. PubMed ID: 26315740
[TBL] [Abstract][Full Text] [Related]
7. Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study.
Popma JJ; Reardon MJ; Khabbaz K; Harrison JK; Hughes GC; Kodali S; George I; Deeb GM; Chetcuti S; Kipperman R; Brown J; Qiao H; Slater J; Williams MR
JACC Cardiovasc Interv; 2017 Feb; 10(3):268-275. PubMed ID: 28183466
[TBL] [Abstract][Full Text] [Related]
8. Predictors of permanent pacemaker implantation after transcatheter aortic valve implantation for aortic stenosis using Medtronic new generation self-expanding CoreValve Evolut R.
Kaneko H; Hoelschermann F; Seifert M; Tambor G; Okamoto M; Moeller V; Neuss M; Butter C
Heart Vessels; 2019 Feb; 34(2):360-367. PubMed ID: 30083944
[TBL] [Abstract][Full Text] [Related]
9. Impact of the repositionable Evolut R CoreValve system on the need for a permanent pacemaker after transcatheter aortic valve implantation in patients with severe aortic stenosis.
Ojeda S; Hidalgo F; Romero M; Mazuelos F; Suárez de Lezo J; Martín E; Lostalo A; Luque A; González R; Fernández A; López-Aguilera J; Segura J; Guerrero N; Pan M
Catheter Cardiovasc Interv; 2020 Mar; 95(4):783-790. PubMed ID: 31062927
[TBL] [Abstract][Full Text] [Related]
10. Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis.
Noble S; Stortecky S; Heg D; Tueller D; Jeger R; Toggweiler S; Ferrari E; Nietlispach F; Taramasso M; Maisano F; Grünenfelder J; Jüni P; Huber C; Carrel T; Windecker S; Wenaweser P; Roffi M
EuroIntervention; 2017 Apr; 12(18):e2170-e2176. PubMed ID: 28067197
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis: SCOPE 2 Randomized Clinical Trial.
Tamburino C; Bleiziffer S; Thiele H; Scholtz S; Hildick-Smith D; Cunnington M; Wolf A; Barbanti M; Tchetchè D; Garot P; Pagnotta P; Gilard M; Bedogni F; Van Belle E; Vasa-Nicotera M; Chieffo A; Deutsch O; Kempfert J; Søndergaard L; Butter C; Trillo-Nouche R; Lotfi S; Möllmann H; Joner M; Abdel-Wahab M; Bogaerts K; Hengstenberg C; Capodanno D
Circulation; 2020 Dec; 142(25):2431-2442. PubMed ID: 33054367
[TBL] [Abstract][Full Text] [Related]
12. Short term clinical outcomes and analysis of risk factors for pacemaker implantation: a single center experience of self-expandable TAVI valves.
Chow SCY; Wong RHL; Cheung GSH; Lee APW; Chui HKL; So KCY; Wu EB
J Cardiothorac Surg; 2020 Jul; 15(1):200. PubMed ID: 32727521
[TBL] [Abstract][Full Text] [Related]
13. Early Outcomes With the Evolut PRO Repositionable Self-Expanding Transcatheter Aortic Valve With Pericardial Wrap.
Forrest JK; Mangi AA; Popma JJ; Khabbaz K; Reardon MJ; Kleiman NS; Yakubov SJ; Watson D; Kodali S; George I; Tadros P; Zorn GL; Brown J; Kipperman R; Saul S; Qiao H; Oh JK; Williams MR
JACC Cardiovasc Interv; 2018 Jan; 11(2):160-168. PubMed ID: 29348010
[TBL] [Abstract][Full Text] [Related]
14. Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial.
Makkar RR; Cheng W; Waksman R; Satler LF; Chakravarty T; Groh M; Abernethy W; Russo MJ; Heimansohn D; Hermiller J; Worthley S; Chehab B; Cunningham M; Matthews R; Ramana RK; Yong G; Ruiz CE; Chen C; Asch FM; Nakamura M; Jilaihawi H; Sharma R; Yoon SH; Pichard AD; Kapadia S; Reardon MJ; Bhatt DL; Fontana GP
Lancet; 2020 Sep; 396(10252):669-683. PubMed ID: 32593323
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of three different new generation transcatheter aortic valve prostheses.
Costa G; Buccheri S; Barbanti M; Picci A; Todaro D; Di Simone E; La Spina K; D'Arrigo P; Criscione E; Nastasi M; Sgroi C; Tamburino C
Catheter Cardiovasc Interv; 2020 Feb; 95(3):398-407. PubMed ID: 31609073
[TBL] [Abstract][Full Text] [Related]
16. Transcathether aortic valve implantation with the new repositionable self-expandable Medtronic Evolut R vs. CoreValve system: evidence on the benefit of a meta-analytical approach.
Kowalewski M; Gozdek M; Raffa GM; Słomka A; Zieliński K; Kubica J; Anisimowicz L; Kowalewski J; Landes U; Kornowski R; Lorusso R; Suwalski P
J Cardiovasc Med (Hagerstown); 2019 Apr; 20(4):226-236. PubMed ID: 30829877
[TBL] [Abstract][Full Text] [Related]
17. Transcatheter Aortic Valve Replacement With Next-Generation Self-Expanding Devices: A Multicenter, Retrospective, Propensity-Matched Comparison of Evolut PRO Versus Acurate neo Transcatheter Heart Valves.
Pagnesi M; Kim WK; Conradi L; Barbanti M; Stefanini GG; Zeus T; Pilgrim T; Schofer J; Zweiker D; Testa L; Taramasso M; Hildick-Smith D; Abizaid A; Wolf A; Van Mieghem NM; Sedaghat A; Wöhrle J; Khogali S; Van der Heyden JAS; Webb JG; Estévez-Loureiro R; Mylotte D; MacCarthy P; Brugaletta S; Hamm CW; Bhadra OD; Schäfer U; Costa G; Tamburino C; Cannata F; Reimers B; Veulemans V; Asami M; Windecker S; Eitan A; Schmidt A; Bianchi G; Bedogni F; Saccocci M; Maisano F; Alsanjari O; Siqueira D; Jensen CJ; Naber CK; Ziviello F; Sinning JM; Seeger J; Rottbauer W; Brouwer J; Alenezi A; Wood DA; Tzalamouras V; Regueiro A; Colombo A; Latib A
JACC Cardiovasc Interv; 2019 Mar; 12(5):433-443. PubMed ID: 30846081
[TBL] [Abstract][Full Text] [Related]
18. Timing of Onset and Outcome of New Conduction Abnormalities Following Transcatheter Aortic Valve Implantation: Role of Balloon Aortic Valvuloplasty.
Campelo-Parada F; Nombela-Franco L; Urena M; Regueiro A; Jiménez-Quevedo P; Del Trigo M; Chamandi C; Rodríguez-Gabella T; Auffret V; Abdul-Jawad Altisent O; DeLarochellière R; Paradis JM; Dumont E; Philippon F; Pérez-Castellano N; Puri R; Macaya C; Rodés-Cabau J
Rev Esp Cardiol (Engl Ed); 2018 Mar; 71(3):162-169. PubMed ID: 28566243
[TBL] [Abstract][Full Text] [Related]
19. Outcomes for the Commercial Use of Self-Expanding Prostheses in Transcatheter Aortic Valve Replacement: A Report From the STS/ACC TVT Registry.
Sorajja P; Kodali S; Reardon MJ; Szeto WY; Chetcuti SJ; Hermiller J; Chenoweth S; Adams DH; Popma JJ
JACC Cardiovasc Interv; 2017 Oct; 10(20):2090-2098. PubMed ID: 29050627
[TBL] [Abstract][Full Text] [Related]
20. Improvements of Procedural Results With a New-Generation Self-Expanding Transfemoral Aortic Valve Prosthesis in Comparison to the Old-Generation Device.
Gomes B; Geis NA; Chorianopoulos E; Meder B; Leuschner F; Katus HA; Bekeredjian R
J Interv Cardiol; 2017 Feb; 30(1):72-78. PubMed ID: 27882613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
